TONX TON Strategy Co.

The $35 Million Vision So, Slippery Rock University decides it's time to beef up their resources with a bold $35 million fundraising campaign, aptly titled “Because this is The Rock.” It's been over 30 years since SRU last rolled out a comprehensive campaign, which makes this push not just ambitious but also crucial. As of the public phase launch on October 23,...

When Buildings Fall and Heavy Equipment Matters Buildings aren't supposed to just topple over. It's not some new trend I missed, but when it does happen, you've got a crisis – and that's exactly what unfolded in Nairobi on October 23 when an 18-story tower gave out, crashing down into chaos in the Eastleigh neighborhood. From Ground Zero to Immediate Response Imagine...

Frozen cinnamon rolls zapping to perfection in 45 seconds? Someone tell my breakfast table it's about to be revolutionized. Sunshine Buns is taking a giant leap into the spotlight as they hit the shelves of Target stores across the U.S. This isn’t just a nice little upturn—this is a potential game-changer for the frozen pastries aisle. A Sweet Deal Gets Sweeter Now,...

Setting the Global Stage for Chinese Pharmaceutical Innovation Ah, China is no longer just the factory of the world; it's rolling its sleeves up and getting deep into the pharma game. Hengrui Pharma, a heavyweight in China's pharmaceutical scene, just pulled off a commendable performance at the European Society for Medical Oncology (ESMO) Congress 2026 over in Madrid....

Breaking New Ground in Cancer Care There's a shift happening in the realm of cancer treatment, and OneOncology's latest study on tarlatamab is right at the forefront. Bringing advanced therapies closer to home isn't just a pipe dream anymore. This real-world study, unveiled at the 2026 ESMO Congress, underscores that administering tarlatamab in outpatient settings might...

Anticipation Builds for NACCO's Q3 Financial Insights From the streets of Cleveland, NACCO Industries is ramping up to release their third quarter financial results for 2026. Mark your calendars for November 4, just after the market packs up for the day. Now, isn't it something to watch how these earnings reports seem to become a spectacle all their own? Promising...

Anavex Under Fire: Investor Rights at the Forefront Another day, another lawsuit makin' waves in that fragile sea called the stock market. This time, it's Anavex Life Sciences Corp. (NASDAQ: AVXL) getting dunked in the soup for allegedly misleading their investors, leaving a bunch of folks wringing their hands and wallets. What's the Beef with Anavex? We've got a class...

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Honoring Trailblazers in Type 1 Diabetes Research It's not every day that we get to shine a spotlight on the unsung heroes in the field of Type 1 Diabetes (T1D) research. Today, we pause to celebrate those who are doing the heavy lifting to make the lives of millions better. Breakthrough T1D, the name says it all, presented its prestigious awards to four titans of...

A Rating That Speaks Volumes in Affordable Housing Fresh out of Rancho Cucamonga, National CORE's announcement of its A+ credit rating reaffirmation is no small potatoes. For the fourth consecutive year, Standard & Poor's Global Ratings has found that this nonprofit affordable housing developer checks all the right boxes for financial strength and strategic prowess. It's...

Royal Caribbean Unveils New Artists for Their Discovery Program The Artist Discovery Program shines a spotlight on the creative expressions of Caribbean artists aboard the cruise line's latest ship, Star of the Seas. Celebrating Local Culture Through Art At Royal Caribbean, celebrating local cultures is paramount. As the cruise line embarks on a journey to showcase the...

Neumora Therapeutics Faces Class Action Lawsuit Recently, a class action lawsuit has been initiated against Neumora Therapeutics, Inc. (NASDAQ: NMRA), a clinical-stage biopharmaceutical company. This legal action has been brought forth by investors who claim they were misled by the company’s initial public offering (IPO) documents. The allegations denote a significant...

LaSalle Investment Management Acquires Tempe Commerce Park LaSalle Investment Management has recently announced a significant acquisition, continuing to bolster its portfolio in the industrial real estate sector. The company has successfully acquired Tempe Commerce Park, an extensive industrial complex located in a metropolitan area renowned for its growth and...

Effective Strategies for Water Conservation Homeowners across the country are increasingly recognizing the importance of water conservation. By taking small, proactive measures, families can significantly lower their water usage and reduce utility costs. Plumbing professionals emphasize the value of implementing water-efficient practices that not only benefit the...

Soleno Therapeutics Announces Inducement Grants Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company focused on creating innovative treatments for rare diseases, has revealed that it has granted inducement awards to six new employees, in accordance with Nasdaq Stock Market regulations. Details of the Inducement Awards The...